78
49
Growth Score
-7 pts
Heat Score
28 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
968821
Elixie is a biotechnology company that develops nano-functionalized cannabinoid drugs.
- Yaron Shoob: Founder & CEO
- Amir Garfunkel: COO
About the Company
Elixie is a biotechnology company. That focuses on creating medicinal cannabis products through its patented Nanolix technology, a self-nanoemulsifying drug delivery platform that boosts oral absorption of cannabinoids. The company formulates liquid and solid dosage forms designed for fast onset, precise dosing, and consistent effects. Elixie
conducts clinical validation and collaborates with research and medical institutions to support its product pipeline. Elixie serves patients living with chronic conditions by offering therapeutic products that aim to maximize efficacy with lower doses and predictable performance.
